Login / Signup

Elevated heart rate and decreased muscle endothelial nitric oxide synthase in early development of insulin resistance.

Sarah J BlackwoodDominik TischerMyrthe P F van de VenMarjan PonténSebastian EdmanOscar HorwathWilliam ApróJulia RöjaMaria M EkblomMarcus MobergAbram Katz
Published in: American journal of physiology. Endocrinology and metabolism (2024)
Insulin resistance (IR) is a risk factor for the development of several major metabolic diseases. Muscle fiber composition is established early in life and is associated with insulin sensitivity. Hence, muscle fiber composition was used to identify early defects in the development of IR in healthy young individuals in the absence of clinical manifestations. Biopsies were obtained from the thigh muscle, followed by an intravenous glucose tolerance test. Indices of insulin action were calculated and cardiovascular measurements, analyses of blood and muscle were performed. Whole body insulin sensitivity (SI galvin ) was positively related to expression of type I muscle fibers ( r = 0.49; P < 0.001) and negatively related to resting heart rate (HR, r = -0.39; P < 0.001), which was also negatively related to expression of type I muscle fibers ( r = -0.41; P < 0.001). Muscle protein expression of endothelial nitric oxide synthase (eNOS), whose activation results in vasodilation, was measured in two subsets of subjects expressing a high percentage of type I fibers (59 ± 6%; HR = 57 ± 9 beats/min; SI galvin = 1.8 ± 0.7 units) or low percentage of type I fibers (30 ± 6%; HR = 71 ± 11; SI galvin = 0.8 ± 0.3 units; P < 0.001 for all variables vs. first group). eNOS expression was 1 ) higher in subjects with high type I expression; 2 ) almost twofold higher in pools of type I versus II fibers; 3 ) only detected in capillaries surrounding muscle fibers; and 4 ) linearly associated with SI galvin . These data demonstrate that an altered function of the autonomic nervous system and a compromised capacity for vasodilation in the microvasculature occur early in the development of IR. NEW & NOTEWORTHY Insulin resistance (IR) is a risk factor for the development of several metabolic diseases. In healthy young individuals, an elevated heart rate (HR) correlates with low insulin sensitivity and high expression of type II skeletal muscle fibers, which express low levels of endothelial nitric oxide synthase (eNOS) and, hence, a limited capacity to induce vasodilation in response to insulin. Early targeting of the autonomic nervous system and microvasculature may attenuate development of diseases stemming from insulin resistance.
Keyphrases